(Circulation. 2007;116:134-142.)
© 2007 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Instituto de Investigaciones Biomédicas (A.M.-D., S.C.-Q., M.T.T.-L.), Universidad Nacional Autónoma de México; the Instituto Nacional de Ciencias Médicas y Nutrición (A.M.-D., S.C.-Q., M.T.T.-L.), Salvador Zubirán, México; the Departments of Medicine and Physiology (T.K., B.Y., C.V., K.U., J.C.M.), University of Wisconsin, Madison.; the Mayo Medical School (A.I., M.J.A.), the Department of Molecular Pharmacology and Experimental Therapeutics (A.M.-D., D.J.T., M.J.A.), the Department of Medicine/Division of Cardiovascular Diseases (M.J.A.), and the Department of Pediatric and Adolescent Medicine/Division of Pediatric Cardiology (M.J.A.), Mayo Clinic College of Medicine, Rochester, Minn.; the Instituto Nacional de Cardiología (P.I.-T.), Ignacio Chávez, México.
Correspondence to Michael J. Ackerman, MD, PhD, Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory, Guggenheim 501, Mayo Clinic College of Medicine, Rochester, MN 55905. E-mail ackerman.michael{at}mayo.edu
Received August 17, 2006; accepted April 20, 2007.
Background— Congenital long-QT syndrome (LQTS) is potentially lethal secondary to malignant ventricular arrhythmias and is caused predominantly by mutations in genes that encode cardiac ion channels. Nearly 25% of patients remain without a genetic diagnosis, and genes that encode cardiac channel regulatory proteins represent attractive candidates. Voltage-gated sodium channels have a pore-forming
-subunit associated with 1 or more auxiliary β-subunits. Four different β-subunits have been described. All are detectable in cardiac tissue, but none have yet been linked to any heritable arrhythmia syndrome.
Methods and Results— We present a case of a 21-month-old Mexican-mestizo female with intermittent 2:1 atrioventricular block and a corrected QT interval of 712 ms. Comprehensive open reading frame/splice mutational analysis of the 9 established LQTS-susceptibility genes proved negative, and complete mutational analysis of the 4 Navβ-subunits revealed a L179F (C535T) missense mutation in SCN4B that cosegregated properly throughout a 3-generation pedigree and was absent in 800 reference alleles. After this discovery, SCN4B was analyzed in 262 genotype-negative LQTS patients (96% white), but no further mutations were found. L179F was engineered by site-directed mutagenesis and heterologously expressed in HEK293 cells that contained the stably expressed SCN5A-encoded sodium channel
-subunit (hNaV1.5). Compared with the wild-type, L179F-β4 caused an 8-fold (compared with SCN5A alone) and 3-fold (compared with SCN5A + WT-β4) increase in late sodium current consistent with the molecular/electrophysiological phenotype previously shown for LQTS-associated mutations.
Conclusions— We provide the seminal report of SCN4B-encoded Navβ4 as a novel LQT3-susceptibility gene.
This article has been cited by other articles:
![]() |
P. J. Schwartz, M. Stramba-Badiale, L. Crotti, M. Pedrazzini, A. Besana, G. Bosi, F. Gabbarini, K. Goulene, R. Insolia, S. Mannarino, et al. Prevalence of the Congenital Long-QT Syndrome Circulation, November 3, 2009; 120(18): 1761 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J N Johnson and M J Ackerman QTc: how long is too long? Br. J. Sports Med., September 1, 2009; 43(9): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. George Jr Genetic Modulation of Impaired Cardiac Conduction: Sodium Channel {beta}4 Subunit Missing in Action Circ. Res., June 5, 2009; 104(11): 1238 - 1239. [Full Text] [PDF] |
||||
![]() |
C. A. Remme, B. P. Scicluna, A. O. Verkerk, A. S. Amin, S. van Brunschot, L. Beekman, V. H.M. Deneer, C. Chevalier, F. Oyama, H. Miyazaki, et al. Genetically Determined Differences in Sodium Current Characteristics Modulate Conduction Disease Severity in Mice With Cardiac Sodium Channelopathy Circ. Res., June 5, 2009; 104(11): 1283 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanabe, D. Darbar, D. W. Kaiser, K. Jiramongkolchai, S. Chopra, B. S. Donahue, P. J. Kannankeril, and D. M. Roden Mutations in Sodium Channel {beta}1- and {beta}2-Subunits Associated With Atrial Fibrillation Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 268 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hu, H. Barajas-Martinez, E. Burashnikov, M. Springer, Y. Wu, A. Varro, R. Pfeiffer, T. T. Koopmann, J. M. Cordeiro, A. Guerchicoff, et al. A Mutation in the {beta}3 Subunit of the Cardiac Sodium Channel Associated With Brugada ECG Phenotype Circ Cardiovasc Genet, June 1, 2009; 2(3): 270 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Elkayam, M. W. Akhter, M. Liu, P. Hatamizadeh, and M. N. Barakat Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography. J. Am. Coll. Cardiol. Img., November 1, 2008; 1(6): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ruan, N. Liu, C. Napolitano, and S. G. Priori Therapeutic Strategies for Long-QT Syndrome: Does the Molecular Substrate Matter? Circ Arrhythm Electrophysiol, October 1, 2008; 1(4): 290 - 297. [Full Text] [PDF] |
||||
![]() |
Y. Rudy, M. J. Ackerman, D. M. Bers, C. E. Clancy, S. R. Houser, B. London, A. D. McCulloch, D. A. Przywara, R. L. Rasmusson, R. J. Solaro, et al. Systems Approach to Understanding Electromechanical Activity in the Human Heart: A National Heart, Lung, and Blood Institute Workshop Summary Circulation, September 9, 2008; 118(11): 1202 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ueda, C. Valdivia, A. Medeiros-Domingo, D. J. Tester, M. Vatta, G. Farrugia, M. J. Ackerman, and J. C. Makielski Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex PNAS, July 8, 2008; 105(27): 9355 - 9360. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goldenberg and A. J. Moss Long QT syndrome. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2291 - 2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abriel Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studies Cardiovasc Res, December 1, 2007; 76(3): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Van Norstrand, C. R. Valdivia, D. J. Tester, K. Ueda, B. London, J. C. Makielski, and M. J. Ackerman Molecular and Functional Characterization of Novel Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Mutations in Sudden Infant Death Syndrome Circulation, November 13, 2007; 116(20): 2253 - 2259. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |